デフォルト表紙
市場調査レポート
商品コード
1469149

バイオインプラント市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、材料別、エンドユーザー別、地域別、競合別、2019年~2029年

Bio-Implants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Material, By End User, By Region and Competition, 2019-2029F

出版日: | 発行: TechSci Research | ページ情報: 英文 180 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

バイオインプラント市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、材料別、エンドユーザー別、地域別、競合別、2019年~2029年
出版日: 2024年04月23日
発行: TechSci Research
ページ情報: 英文 180 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

バイオインプラントの世界市場は、2023年に1,253億米ドルと評価され、2029年までのCAGRは10.70%で、予測期間中に力強い成長が予測されています。

バイオインプラントは、骨の修復、置換、骨治癒の補助を目的として医療用途に利用される生体合成材料です。インプラント生地の主な役割は、骨折に安定性を与え、骨とインプラントの界面での動きを最小限に抑えることで器質的な骨の回復を促進することです。生体インプラントに一般的に使用される金属はチタンとその合金で、卓越した耐食性、高エネルギー、生体適合性で知られ、外科用インプラントとして広く使用されています。生体インプラントは、生体構造を置換、支持、強化するために使用される人工器官です。コラーゲンのような様々な生合成材料や、人工皮膚のような組織工学製品で構成されています。バイオインプラントは、バイオ人工臓器、細胞治療、組織工学を含む生物学的インプラント、生体内細胞ライニング、技術的インプラント、バイオハイブリッドシステムを含む生物学的インプラント、表面機能化インプラントや薬剤溶出ステントを含む生物学的機能化インプラントの3つの主要グループに分類されます。耳鼻咽喉科の分野では、バイオインプラントが外科手術で大きな成功を収め、患者の生理機能を効果的に調整し、生産的な生活を送ることを可能にしています。

主な市場促進要因

老年人口の増加

低侵襲手術への嗜好の高まり

治療用途の拡大

技術の進歩

主な市場課題

インプラント手術の高コスト

生体材料の受容体への適応

主な市場動向

ストレスの多いライフスタイルによる慢性疾患の増加

遺伝子組み換え生体材料

セグメント別インサイト

製品タイプ別インサイト

材料別インサイト

地域別インサイト

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 バイオインプラントの世界市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品タイプ別(心臓血管インプラント、脊椎インプラント、整形外科インプラント、歯科インプラント、眼科インプラント、その他インプラント)
    • 材料別(生体材料金属合金、セラミック、ポリマー、その他材料)
    • エンドユーザー別(病院クリニック、外来手術センター、その他)
    • 地域別
    • 企業別(2023年)
  • 市場マップ

第6章 北米のバイオインプラント市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品タイプ別
    • 材料別
    • エンドユーザー別
    • 国別
  • 北米:国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州のバイオインプラント市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品タイプ別
    • 材料別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン

第8章 アジア太平洋のバイオインプラント市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品タイプ別
    • 材料別
    • エンドユーザー別
    • 国別
  • アジア太平洋:国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米のバイオインプラント市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品タイプ別
    • 材料別
    • エンドユーザー別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのバイオインプラント市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品タイプ別
    • 材料別
    • エンドユーザー別
    • 国別
  • MEA:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の展開
  • 合併・買収
  • 製品上市

第13章 バイオインプラントの世界市場SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • BIOTRONIK SE Co. KG
  • Invibio Limited
  • Wright MedicalGroup N.V.
  • Edwards Lifesciences Corporation
  • MiMeDX Group Inc.
  • Stryker Corporation
  • Endo International plc
  • Smith Nephews plc
  • Zimmer Biomet Holdings Inc
  • Ethicon Inc.

第16章 戦略的提言

第17章 免責事項

目次
Product Code: 4961

Global Bio-Implants Market was valued at USD 125.30 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 10.70% through 2029. Bio-implants are biosynthetic materials utilized in medical applications for the purpose of bone repair, replacement, or aiding in bone healing. The primary role of implant fabric is to provide stability to bone fractures and facilitate organic bone recovery by minimizing movement at the bone-implant interface. The metals commonly used in bio-implants are titanium and its alloys, known for their exceptional corrosion resistance, high energy, and biocompatibility, making them widely used as surgical implants. Bio-implants are prostheses employed to replace, support, or enhance biological structures. They consist of various biosynthetic materials such as collagen and tissue-engineered products like artificial skin. Bio-implants are categorized into three major groups: biological implants encompassing bioartificial organs, cell therapy, and tissue engineering; biologized implants comprising in-vivo cell lining, technical implants, and biohybrid systems; and biofunctionalized implants including surface-functionalized implants and drug-eluting stents. In the field of ENT, bio-implants have yielded highly successful surgical outcomes, effectively regulated patients' physiological functions and enabling them to lead productive lives.

Key Market Drivers

Rising Geriatric Population

The population of elderly individuals, aged 80 and above, is on the rise due to improved living standards and advancements in the medical field. Older adults tend to avoid lengthy medical treatments, which is expected to drive the demand for bio-implants in this age group in the coming years. Surgeons often avoid major operations in older patients due to concerns about medical complications, which contributes to market growth. The most common ailments among geriatric individuals are related to eyesight and joint issues. Addressing these conditions can be achieved through the use of retinal bioimplants and knee or hip joint replacements. Current market trends suggest that the elderly population is set to increase, with more noticeable effects in nations with a high HDI such as Korea and the United States. Considering the frequent use of bio-implants in orthopedic treatments, this development holds significant implications for the market. Hip fractures rank among the most prevalent catastrophic injuries among the elderly, often necessitating immediate surgery and anesthesia. Consequently, patients spend several weeks in the hospital, resulting in the utilization of 1.5 million hospital bed days each year. As per NICE recommendations, surgical intervention should be conducted on the same day as hospital admission or the following day. This approach is informed by the understanding that being bedridden with a hip fracture is an unpleasant, distressing, and debilitating experience for patients, who are unable to mobilize until the procedure is completed. Thus, the expanding geriatric population is driving the growth of the Bio-implant Market.

Rising Preference toward Minimally Invasive Surgeries

A significant trend observed in the bioimplants market is the increasing demand for minimally invasive surgeries. The ability to create precise incisions for accessing surgical points is a significant advantage of these procedures. Minimally invasive surgeries enable endoscopic and laparoscopic bio-implanting procedures, resulting in reduced pain and faster postoperative recovery.

Minimally invasive surgeries offer significant benefits in terms of reducing post-surgical complications, promoting quick recovery, and shortening hospital stays. Procedures such as laser surgery, endoscopy, and laparoscopy involve small incisions, effectively minimizing pain and morbidity while enhancing postoperative recovery. The convenience of minimally invasive surgeries also drives the utilization of small bioimplants, smart tools, and devices. As a result, the preference for minimally invasive surgeries is poised to grow, making it a key trend in the bioimplants market in the coming years.

Increasing Range of Therapeutic Uses

Bio-implants have a wide range of therapeutic applications in various domains such as orthopedics, cardiology, dentistry, neurology, and more. They play a crucial role in enhancing both the duration and quality of human life. Moreover, bio-implants are utilized in the treatment of skin burns or wounds resulting from surgical procedures. Additionally, the increasing aging population, which is more susceptible to chronic conditions like cardiovascular disease, orthopedic disorders, endovascular diseases, and dental disorders, is one of the key drivers behind the growth of the Bio-Implants Market. Numerous chronic diseases, such as gout, congenital and neuropathic disorders, and cardiovascular diseases (CVD), have sedentary lifestyles as their primary contributing factor. Consequently, the global market for bio-implants has witnessed significant growth.

Technological advancement

Technological advancements in bio-implant manufacturing, such as 3D printing, laser technology, and nanotechnology, have significantly enhanced the biocompatibility of these products. A key contributing factor to these advancements is the increased allocation of healthcare funding by governments worldwide. Several governmental organizations are collaborating with healthcare research firms and medical equipment manufacturers to introduce novel and more efficacious devices to the market. Post-acute myocardial heart attack, the inclusion of extracellular vesicles from stem cells in bio implants has shown improved cardiac performance. The growing prevalence of cardiovascular diseases globally serves as the primary driver for the expansion of this market segment. Moreover, the increasing geriatric population worldwide presents a promising avenue for market growth throughout the forecast period. For instance, as per a 2021 essay published by the American Heart Association, approximately 40,000 children undergo congenital heart surgery annually in the United States.

Key Market Challenges

High Cost of Implanting Procedures

Implant procedures are significantly expensive due to the high costs associated with importing implant materials and the expertise required by skilled surgeons. For instance, dental implants for a single tooth typically fall within the higher price range. Similarly, the costs of treating chronic conditions with essential organ implants are exorbitant. These include retinal implants, cardiac stents, spinal implants, and cosmetic implants, all of which have the potential to restrict market growth.

Biomaterial Adaptation to Receptive Bodies

The efficacy of embedded implants in the human body is directly correlated with the body's adaptation to the material. The likelihood of immune reactions in the body plays a crucial role in assessing this efficacy. Infections resulting from implant materials have been reported due to bacterial adhesion to biomaterials used for implants, which impacts market growth. Allergic reactions of the body to foreign implanted materials cause discomfort to patients. Treatment in such cases often involves the removal of the implanted material and its replacement with other materials compatible with the body. Challenges arise at the implantation site due to material rejection by the human body, which manifests as inflammation and infections in and around the implant site.

Key Market Trends

Increasing Chronic Diseases due to Stressful Lifestyles

Chronic diseases affecting the heart, kidneys, and liver are on the rise due to stressful lifestyles and unhealthy habits. These conditions often require treatments such as organ and tissue transplantation, as well as the use of bio-implants. Additionally, degenerative bone and joint problems pose significant challenges. The increasing global geriatric population presents a substantial opportunity for the growth of the bio-implants market. Orthopedic biological implants are preferred for joint replacements and strengthening, addressing deformities caused by natural, accidental, or congenital factors. The utilization of implants, such as pacemakers and stents, for treating cardiovascular diseases is also increasing. This growth is driven by the need for effective control and treatment of heart ailments in the aging population worldwide.

Genetically Engineered Biomaterials

Naturally occurring biomaterials, such as proteins, undergo selective modifications for tissue engineering purposes. This primarily involves cell adhesion, protein fusions, and their applications in gene delivery, cell encapsulation, coating, and drug delivery. These advancements are poised to enhance the growth prospects of the market. Genetically engineered biomaterials involve sequencing processes based on genetics, structure, molecular weights, and fusion chemistries. A surge in the production of biomaterials using physical and chemical combinations in genetic engineering is anticipated. This focused production of biomaterials through intrinsic research contributes to the improvement in the effectiveness of implants. One significant opportunity driving the expansion of the cosmetic biomaterial market is research aimed at developing artificial skin using specialized biomaterials. Various forms of sponges that combine fibrillar collagen and gelatin are under evaluation. The evaluation encompasses in vitro cellular responses and in vivo tissue reactions, including experimentation in a whole organism, such as in vivo cell lining.

Segmental Insights

Product TypeInsights

Based on the product type, the market is categorized into different segments including cardiovascular implants, spinal implants, orthopaedic implants, dental implants, ophthalmic implants, and other implants. Among these, cardiovascular implants dominate the market due to the increasing prevalence of cardiovascular diseases. The geriatric population is also growing, creating further growth opportunities in this segment. Various factors such as smoking, sedentary lifestyle of the young population, and high blood pressure contribute to the development of cardiovascular diseases. Bioimplants are commonly used for treating such conditions, with surgery being the preferred method for most patients. As a result, the market is expected to experience significant expansion throughout the forecast period, as indicated by the analysis.

Material Insights

Based on the material, the biomaterial metal alloys category emerged as the dominant segment in the bio-implant market in 2023 and is projected to maintain its position throughout the forecast period. Key drivers for the category include notable advantages such as superior tensile strength and corrosion resistance compared to ceramics and other materials. Noteworthy applications of biomaterial metals include dental implants, joint replacement implants, and pacemaker cases. Conversely, ceramic implants are anticipated to experience rapid growth during the forecast period. Ceramics have garnered significant attention due to their ability to fulfil crucial mechanical functions for tissue repair. Furthermore, the potential of bio-ceramics to stimulate bone regeneration tissues is expected to drive their adoption in the coming years.

Regional Insights

North America has a dominant presence in the Bio-Implants Market. It is observed to hold a significant share and is projected to maintain this trend in the forecast period without any notable variations. The market growth is primarily driven by the growing incidence of chronic illnesses and the availability of advanced healthcare infrastructure. Europe is the second largest market for bio-implants, attributed to government funding and support, a rise in the prevalence of orthopedic illnesses, and increased RD efforts. For instance, many pacemaker manufacturers focus on developing MRI-conditional and leadless pacemakers. Moreover, the increasing prevalence of cardiovascular diseases (CVD) leads to a higher number of CVD procedures, contributing to market expansion. Asia Pacific is expected to witness the fastest growth throughout the forecast period, primarily due to the rising prevalence of spinal cord injuries. This can be attributed to a significant increase in the number of traffic accidents. According to a 2019 study by Tokyo's Keio University, more than 100,000 individuals in Japan suffer from paralysis caused by spinal cord injuries. However, the recent approval of iPS technology in the country is likely to offer potential for bio-implant market growth in the future, providing assistance to such patients. Therefore, these aforementioned factors are anticipated to propel market growth in the region during the forecast period.

Key Market Players

BIOTRONIK SE Co. KG

Invibio Limited

Wright Medical Group N.V.

Edwards Lifesciences Corporation

MiMeDX Group Inc.

Stryker Corporation

Endo International plc

Smith Nephew plc

Zimmer Biomet Holdings Inc

Ethicon Inc.

Report Scope:

In this report, the Global Bio-Implants Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bio-Implants Market,By Product Type:

  • Cardiovascular Implants
  • Spinal Implants
  • Orthopedic Implants
  • Dental Implants
  • Ophthalmic Implants
  • Other Implants

Bio-Implants Market,By Material:

  • Biomaterial Metal Alloys
  • Ceramics
  • Polymers
  • Other Materials

Bio-Implants Market,By End User:

  • Hospitals Clinics
  • Ambulatory Surgical Centres
  • Others

Bio-Implants Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bio-Implants Market.

Available Customizations:

Global Bio-Implants marketreport with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

  • 1.1.Market Definition
  • 1.2.Scope of the Market
    • 1.2.1.Markets Covered
    • 1.2.2.Years Considered for Study
    • 1.2.3.Key Market Segmentations

2.Research Methodology

  • 2.1.Objective of the Study
  • 2.2.Baseline Methodology
  • 2.3.Key Industry Partners
  • 2.4.Major Association and Secondary Sources
  • 2.5.Forecasting Methodology
  • 2.6.Data Triangulation Validations
  • 2.7.Assumptions and Limitations

3.Executive Summary

  • 3.1.Overview of the Market
  • 3.2.Overview of Key Market Segmentations
  • 3.3.Overview of Key Market Players
  • 3.4.Overview of Key Regions/Countries
  • 3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.Global Bio-Implants Market Outlook

  • 5.1.Market Size Forecast
    • 5.1.1.By Value
  • 5.2.Market Share Forecast
    • 5.2.1.By Product Type (Cardiovascular Implants, Spinal Implants, Orthopaedic Implants, Dental Implants, Ophthalmic Implants, and Other Implants)
    • 5.2.2.By Material (Biomaterial Metal Alloys, Ceramics, Polymers, and Other Materials)
    • 5.2.3.By End User (Hospitals Clinics, Ambulatory Surgical Centres, Others)
    • 5.2.4.By Region
    • 5.2.5.By Company (2023)
  • 5.3.Market Map

6.North America Bio-Implants Market Outlook

  • 6.1.Market Size Forecast
    • 6.1.1.By Value
  • 6.2.Market Share Forecast
    • 6.2.1.ByProduct Type
    • 6.2.2.By Material
    • 6.2.3.By End User
    • 6.2.4.By Country
  • 6.3.North America: Country Analysis
    • 6.3.1.United States Bio-Implants Market Outlook
      • 6.3.1.1.Market Size Forecast
        • 6.3.1.1.1.By Value
      • 6.3.1.2.Market Share Forecast
        • 6.3.1.2.1.By Product Type
        • 6.3.1.2.2.By Material
        • 6.3.1.2.3.By End User
    • 6.3.2.Canada Bio-Implants Market Outlook
      • 6.3.2.1.Market Size Forecast
        • 6.3.2.1.1.By Value
      • 6.3.2.2.Market Share Forecast
        • 6.3.2.2.1.By Product Type
        • 6.3.2.2.2.By Material
        • 6.3.2.2.3.By End User
    • 6.3.3.Mexico Bio-Implants Market Outlook
      • 6.3.3.1.Market Size Forecast
        • 6.3.3.1.1.By Value
      • 6.3.3.2.Market Share Forecast
        • 6.3.3.2.1.By Product Type
        • 6.3.3.2.2.By Material
        • 6.3.3.2.3.By End User

7.Europe Bio-Implants Market Outlook

  • 7.1.Market Size Forecast
    • 7.1.1.By Value
  • 7.2.Market Share Forecast
    • 7.2.1.By Product Type
    • 7.2.2.By Material
    • 7.2.3.By End User
    • 7.2.4.By Country
  • 7.3.Europe: Country Analysis
    • 7.3.1.Germany Bio-Implants Market Outlook
      • 7.3.1.1.Market Size Forecast
        • 7.3.1.1.1.By Value
      • 7.3.1.2.Market Share Forecast
        • 7.3.1.2.1.By Product Type
        • 7.3.1.2.2.By Material
        • 7.3.1.2.3.By End User
    • 7.3.2.United Kingdom Bio-Implants Market Outlook
      • 7.3.2.1.Market Size Forecast
        • 7.3.2.1.1.By Value
      • 7.3.2.2.Market Share Forecast
        • 7.3.2.2.1.By Product Type
        • 7.3.2.2.2.By Material
        • 7.3.2.2.3.By End User
    • 7.3.3.Italy Bio-Implants Market Outlook
      • 7.3.3.1.Market Size Forecast
        • 7.3.3.1.1.By Value
      • 7.3.3.2.Market Share Forecasty
        • 7.3.3.2.1.By Product Type
        • 7.3.3.2.2.By Material
        • 7.3.3.2.3.By End User
    • 7.3.4.France Bio-Implants Market Outlook
      • 7.3.4.1.Market Size Forecast
        • 7.3.4.1.1.By Value
      • 7.3.4.2.Market Share Forecast
        • 7.3.4.2.1.By Product Type
        • 7.3.4.2.2.By Material
        • 7.3.4.2.3.By End User
    • 7.3.5.Spain Bio-Implants Market Outlook
      • 7.3.5.1.Market Size Forecast
        • 7.3.5.1.1.By Value
      • 7.3.5.2.Market Share Forecast
        • 7.3.5.2.1.By Product Type
        • 7.3.5.2.2.By Material
        • 7.3.5.2.3.By End User

8.Asia-Pacific Bio-Implants Market Outlook

  • 8.1.Market Size Forecast
    • 8.1.1.By Value
  • 8.2.Market Share Forecast
    • 8.2.1.By Product Type
    • 8.2.2.By Material
    • 8.2.3.By End User
    • 8.2.4.By Country
  • 8.3.Asia-Pacific: Country Analysis
    • 8.3.1.China Bio-Implants Market Outlook
      • 8.3.1.1.Market Size Forecast
        • 8.3.1.1.1.By Value
      • 8.3.1.2.Market Share Forecast
        • 8.3.1.2.1.By Product Type
        • 8.3.1.2.2.By Material
        • 8.3.1.2.3.By End User
    • 8.3.2.India Bio-Implants Market Outlook
      • 8.3.2.1.Market Size Forecast
        • 8.3.2.1.1.By Value
      • 8.3.2.2.Market Share Forecast
        • 8.3.2.2.1.By Product Type
        • 8.3.2.2.2.By Material
        • 8.3.2.2.3.By End User
    • 8.3.3.Japan Bio-Implants Market Outlook
      • 8.3.3.1.Market Size Forecast
        • 8.3.3.1.1.By Value
      • 8.3.3.2.Market Share Forecast
        • 8.3.3.2.1.By Product Type
        • 8.3.3.2.2.By Material
        • 8.3.3.2.3.By End User
    • 8.3.4.South Korea Bio-Implants Market Outlook
      • 8.3.4.1.Market Size Forecast
        • 8.3.4.1.1.By Value
      • 8.3.4.2.Market Share Forecast
        • 8.3.4.2.1.By Product Type
        • 8.3.4.2.2.By Material
        • 8.3.4.2.3.By End User
    • 8.3.5.Australia Bio-Implants Market Outlook
      • 8.3.5.1.Market Size Forecast
        • 8.3.5.1.1.By Value
      • 8.3.5.2.Market Share Forecast
        • 8.3.5.2.1.By Product Type
        • 8.3.5.2.2.By Material
        • 8.3.5.2.3.By End User

9.South America Bio-Implants Market Outlook

  • 9.1.Market Size Forecast
    • 9.1.1.By Value
  • 9.2.Market Share Forecast
    • 9.2.1.By Product Type
    • 9.2.2.By Material
    • 9.2.3.By End User
    • 9.2.4.By Country
  • 9.3.South America: Country Analysis
    • 9.3.1.Brazil Bio-Implants Market Outlook
      • 9.3.1.1.Market Size Forecast
        • 9.3.1.1.1.By Value
      • 9.3.1.2.Market Share Forecast
        • 9.3.1.2.1.By Product Type
        • 9.3.1.2.2.By Material
        • 9.3.1.2.3.By End User
    • 9.3.2.Argentina Bio-Implants Market Outlook
      • 9.3.2.1.Market Size Forecast
        • 9.3.2.1.1.By Value
      • 9.3.2.2.Market Share Forecast
        • 9.3.2.2.1.By Product Type
        • 9.3.2.2.2.By Material
        • 9.3.2.2.3.By End User
    • 9.3.3.Colombia Bio-Implants Market Outlook
      • 9.3.3.1.Market Size Forecast
        • 9.3.3.1.1.By Value
      • 9.3.3.2.Market Share Forecast
        • 9.3.3.2.1.By Product Type
        • 9.3.3.2.2.By Material
        • 9.3.3.2.3.By End User

10.Middle East and Africa Bio-Implants Market Outlook

  • 10.1.Market Size Forecast
    • 10.1.1.By Value
  • 10.2.Market Share Forecast
    • 10.2.1.By Product Type
    • 10.2.2.By Material
    • 10.2.3.By End User
    • 10.2.4.By Country
  • 10.3.MEA: Country Analysis
    • 10.3.1.South Africa Bio-Implants Market Outlook
      • 10.3.1.1.Market Size Forecast
        • 10.3.1.1.1.By Value
      • 10.3.1.2.Market Share Forecast
        • 10.3.1.2.1.By Product Type
        • 10.3.1.2.2.By Material
        • 10.3.1.2.3.By End User
    • 10.3.2.Saudi Arabia Bio-Implants Market Outlook
      • 10.3.2.1.Market Size Forecast
        • 10.3.2.1.1.By Value
      • 10.3.2.2.Market Share Forecast
        • 10.3.2.2.1.By Product Type
        • 10.3.2.2.2.By Material
        • 10.3.2.2.3.By End User
    • 10.3.3.UAE Bio-Implants Market Outlook
      • 10.3.3.1.Market Size Forecast
        • 10.3.3.1.1.By Value
      • 10.3.3.2.Market Share Forecast
        • 10.3.3.2.1.By Product Type
        • 10.3.3.2.2.By Material
        • 10.3.3.2.3.By End User

11.Market Dynamics

  • 11.1.Drivers
  • 11.2.Challenges

12.Market Trends Developments

  • 12.1.Recent Development
  • 12.2.Mergers Acquisitions
  • 12.3.Product Launches

13.Global Bio-Implants Market: SWOT Analysis

14.Porter's Five Forces Analysis

  • 14.1.Competition in the Industry
  • 14.2.Potential of New Entrants
  • 14.3.Power of Suppliers
  • 14.4.Power of Customers
  • 14.5.Threat of Substitute Products

15.Competitive Landscape

  • 15.1.BIOTRONIK SE Co. KG
    • 15.1.1.Business Overview
    • 15.1.2.Company Snapshot
    • 15.1.3.Products Services
    • 15.1.4.Financials (As Reported)
    • 15.1.5.Recent Developments
    • 15.1.6.Key Personnel Details
    • 15.1.7.SWOT Analysis
  • 15.2.Invibio Limited
  • 15.3.Wright MedicalGroup N.V.
  • 15.4.Edwards Lifesciences Corporation
  • 15.5.MiMeDX Group Inc.
  • 15.6.Stryker Corporation
  • 15.7.Endo International plc
  • 15.8.Smith Nephews plc
  • 15.9.Zimmer Biomet Holdings Inc
  • 15.10.Ethicon Inc.

16.Strategic Recommendations

17.About Us Disclaimer